De-escalation of biological therapy in Inflammatory bowel disease (IBD) and outcomes at week 52: a single centre experience

被引：0
|
作者：
Al-Talib, Ismaeel [1 ]
Iqbal, Majid [1 ]
Shaheen, Sirah [1 ]
Shingadia, Maya [1 ]
Slater, Jayne [1 ]
King, Dominic [1 ]
Rattehalli, Deepa [1 ]
De Silva, Shanika [1 ]
机构：
[1] Dudley Grp NHS Fdn Trust, Dudley, England
来源：
GUT | 2023年 / 72卷 / SUPPL_2期
关键词：
D O I：
10.1136/gutjnl-2023-BSG.132
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P60
引用
收藏
页码：A79 / A79
页数：1
相关论文
共 50 条
  • [11] Inflammatory bowel disease in the clinic: Escalation and de-escalation of therapy: A longitudinal case-based discussion
    Begun, Jakob
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 12 - 13
  • [12] EFFECTIVENESS OF DOSE DE-ESCALATION OF BIOLOGIC THERAPY IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW
    Little, Derek H.
    Tabatabavakili, Sahar
    Shaffer, Seth
    Weizman, Adam V.
    Nguyen, Geoffrey C.
    Targownik, Laura E.
    GASTROENTEROLOGY, 2020, 158 (06) : S670 - S671
  • [13] Effectiveness of Dose De-escalation of Biologic Therapy in Inflammatory Bowel Disease: A Systematic Review
    Little, Derek H. W.
    Tabatabavakili, Sahar
    Shaffer, Seth R.
    Nguyen, Geoffrey C.
    Weizman, Adam, V
    Targownik, Laura E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (11): : 1768 - 1774
  • [14] Inflammatory Bowel Disease (IBD) Nurse Advice Line: A Single Centre Experience
    Forry, M.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S448 - S448
  • [15] THE RISK OF RELAPSE AFTER DOSE DE-ESCALATION OF BIOLOGIC THERAPY IN INFLAMMATORY BOWEL DISEASE (IBD): A SYSTEMATIC REVIEW AND META-ANALYSIS
    Musallam, Rami
    Abu-Shawer, Osama
    Mohan, Babu P.
    Elfert, Khaled
    Aldiabat, Mohammad
    Sayeh, Wasef
    Mouchli, Mohamad
    Mansoor, Emad
    Katz, Jeffry
    Cooper, Gregory S.
    Nguyen, Vu Q.
    GASTROENTEROLOGY, 2023, 164 (06) : S649 - S650
  • [16] De-escalation of Biologic Treatment in Inflammatory Bowel Disease: A Comprehensive Review
    Gisbert, Javier P.
    Chaparro, Maria
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (04): : 642 - 658
  • [17] THIOPURINES IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASES (IBD) - A SINGLE CENTRE EXPERIENCE
    Furfaro, F.
    Costantino, G.
    Alibrandi, A.
    Fries, W.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S199 - S199
  • [18] AZATHIOPRINE/6-MERCAPTOPURINE IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE (IBD) - A SINGLE CENTRE EXPERIENCE
    Costantino, G.
    Sergi, M. D.
    Lo Presti, M. A.
    Della Torre, A.
    Corrente, E.
    Ocera, L.
    Di Benedetto, A.
    Romano, C.
    Fries, W.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S134 - S135
  • [19] Pregnancy Outcomes in Patients with inflammatory bowel disease: A single-centre experience
    Bailey, Y.
    Hanna, C.
    O'Connor, A.
    Breslin, N.
    Ryan, B.
    McNamara, D.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S662 - S662
  • [20] STOPPING BIOLOGICAL THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A 5 YEAR REVIEW OF A SINGLE CENTRE'S EXPERIENCE
    Dattani, V.
    Lithgo, K.
    Price, T.
    Johnson, M. W.
    GUT, 2015, 64 : A240 - A240
12345